Barreiro-González, Antonio http://orcid.org/0000-0001-6500-6938
Sanz, Maria T. http://orcid.org/0000-0002-7146-8087
Carratalà-Boscà, Sara http://orcid.org/0000-0003-0021-3041
Pérez-Miralles, Francisco http://orcid.org/0000-0003-3767-3738
Alcalá, Carmen http://orcid.org/0000-0002-4799-7579
España-Gregori, Enrique http://orcid.org/0000-0003-0809-8279
Casanova, Bonaventura http://orcid.org/0000-0003-3806-925X
Funding for this research was provided by:
Instituto de Salud Carlos III (FIS 17/551)
Article History
Received: 16 April 2020
Accepted: 28 September 2020
First Online: 12 October 2020
Compliance with ethical standards
:
: Francisco Pérez-Miralles has received compensation from Almirall, Biogen Idec, Genzyme, Merk-Serono, Mylan, Novartis, Roche, Sanofi-Aventis, and Teva, outside the submitted work. Bonaventura Casanova has received compensation from Novartis, Roche, Biogen, Merk, Teva, and Sanofi outside the submitted work. All other authors have no conflicts of interest to declare.
: Written informed consent was obtained from all individual participants included in the study.